For investors in 2017, the "high-risk, high-reward" segment of the market was defined by a strong rebound in energy, explosive breakthroughs in biotechnology, and the rising dominance of high-growth technology. While the broader market saw a lack of volatility, with the S&P 500 rising roughly 20% and the Nasdaq nearly 30%, these specific sectors offered triple-digit gains for those willing to stomach higher volatility.
: Aggressive investors also looked at high-yield dividend stocks such as AstraZeneca (AZN) and GameStop (GME) , which offered potential capital appreciation alongside dividends, though they carried elevated risk during market transitions. Key Market Drivers for 2017 high risk stocks to buy 2017
: Nine of the top ten performing stocks of the year were in the biotech sector. Companies like Vertex Pharmaceuticals (VRTX) (up 97%) and Dynavax Technologies (DVAX) (up 373%) succeeded based on FDA approvals and breakthrough trial data. For investors in 2017, the "high-risk, high-reward" segment